about
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomicsN. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory NetworkUtilizing population variation, vaccination, and systems biology to study human immunologySearching for the human genetic factors standing in the way of universally effective vaccinesThe role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbedA genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine AdsorbedNext-generation sequencing: a transformative tool for vaccinology.Adversomics: the emerging field of vaccine adverse event immunogeneticsGenetic determinants of immune-response to a polysaccharide vaccine for typhoid.Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines.Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.The genetic regulation of infant immune responses to vaccination.Vaccinomics: current findings, challenges and novel approaches for vaccine developmentMultigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.Consistency of HLA associations between two independent measles vaccine cohorts: a replication studyHuman leukocyte antigen associations with humoral and cellular immunity following a second dose of measles-containing vaccine: persistence, dampening, and extinction of associations found after a first dose.Reduced Human Leukocyte Antigen (HLA) Protection in Gulf War Illness (GWI).Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.HLA-DR: molecular insights and vaccine design.Associations between polymorphisms in the antiviral TRIM genes and measles vaccine immunity.Genomic correlates of variability in immune response to an oral cholera vaccine.Application of pharmacogenomics to vaccines.The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.Pattern recognition receptor-mediated cytokine response in infants across 4 continents.Challenges in the research and development of new human vaccines.The role of Toll-like receptor 4 polymorphisms in vaccine immune response.B cell antigen receptor endocytosis and antigen presentation to T cells require Vav and dynamin.Personalized vaccinology: A review.Surfing a genetic association interaction network to identify modulators of antibody response to smallpox vaccinePandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children.Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology.Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults.Genes controlling vaccine responses and disease resistance to respiratory viral pathogens in cattle.Personalized vaccines: the emerging field of vaccinomics
P2860
Q24648874-67514FB3-E1B9-4334-A7B1-9E0D945AD4BEQ26744800-8E077E0B-3459-4D2E-B3B3-B9A2458600C7Q26799374-57D1070D-8491-472D-A77C-6BC1617E8DFFQ27007034-C8CD8A55-E017-4E76-A20D-D22498F018C3Q28391462-BAA648F0-D29B-4AD2-93DA-7708F5E8312EQ28943460-C7AB0F94-E982-4B2B-8028-876D867367E2Q33744262-FE617A35-5EB1-4A5A-B757-0FE29DC3227CQ33744268-6C7F623E-AAA1-4FAF-8193-617B999E47A3Q33901610-CE58B965-B8C4-4C52-B66A-F7E40C08CF69Q34033774-F87A8417-5CCF-470D-808B-037D04086A91Q34126261-B25A6A29-886B-4D70-9B2F-6B15916F5904Q34345266-2BB2E6A1-BC4D-494B-BA0F-39810796B605Q35037615-AF7FBC3C-08BC-4D46-8282-FE9199F4F0DBQ35176899-DE1D19C5-3BD5-4830-A410-29F830024ADFQ35784185-61A27AD0-EE47-42C4-87C3-ACD8134FDB6AQ35785581-BF08579C-3148-472F-A91B-AB6B9BBE0140Q35869228-81BA0032-0E7C-45BA-B6E5-B762804315B0Q36538821-00BE8F2D-0D1E-4A49-8DEE-B291CC027BACQ36733384-0F9903D6-8C91-4305-8411-5D1D6F073A71Q36737531-B4F138E2-F079-4D25-B6E6-4E0695A8F17DQ36816196-A6A68437-06CD-4591-BED6-3B76C307811BQ37102102-6090F3A7-7BD2-42F8-86E0-2F6FC38CDDD7Q37293663-A0F9EBCA-FAD6-4BCC-8404-75958BE495E3Q37583889-35332291-1527-4D7A-BB7A-9379BAC0FBC0Q37672021-53351C24-D93A-4B97-9511-15D6E7726009Q38096300-89520B02-D11E-4F7E-80DC-D0587637F152Q38396207-7DA608ED-C499-4DCB-9F16-FD0C7A336236Q39827413-15993369-A860-4DC2-9E30-76E2477A9742Q40107665-DA922477-A2FD-499E-933B-E51F28C692F2Q41154965-0895836B-C297-48B6-9A8F-0BB97DB18290Q41989822-7AB69FB2-8BFA-4078-91F5-0E1D15C5F216Q42040401-192E097F-8050-4293-8008-C37D669FABB5Q42104268-680C8548-3884-4A31-A267-CD6572AE8540Q42265533-5C1529E8-3398-4A8F-9903-85DF48AF3218Q57157844-30F8EA90-DAC6-42CC-B7D8-DCCF39658351
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccine immunogenetics: bedside to bench to population.
@en
Vaccine immunogenetics: bedside to bench to population.
@nl
type
label
Vaccine immunogenetics: bedside to bench to population.
@en
Vaccine immunogenetics: bedside to bench to population.
@nl
prefLabel
Vaccine immunogenetics: bedside to bench to population.
@en
Vaccine immunogenetics: bedside to bench to population.
@nl
P2860
P1433
P1476
Vaccine immunogenetics: bedside to bench to population.
@en
P2093
Robert M Jacobson
P2860
P304
P356
10.1016/J.VACCINE.2008.06.057
P407
P577
2008-07-01T00:00:00Z